
CASI Pharmaceuticals CASI
$ 0.79
4.29%
Quarterly report 2022-Q3
added 11-14-2022
CASI Pharmaceuticals Total Current Liabilities 2011-2026 | CASI
Annual Total Current Liabilities CASI Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 13.2 M | 7.98 M | 7.95 M | 3.87 M | 5.06 M | 1.32 M | 1.05 M | 919 K | 565 K | 743 K | 704 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.2 M | 565 K | 3.94 M |
Total Current Liabilities of other stocks in the Biotechnology industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acasti Pharma
ACST
|
1.93 M | - | 4.01 % | $ 150 M | ||
|
Adverum Biotechnologies
ADVM
|
22.9 M | - | - | $ 86.2 M | ||
|
ARCA biopharma
ABIO
|
13 M | - | 1052.0 % | $ 415 M | ||
|
AgeX Therapeutics
AGE
|
5.91 M | - | -10.17 % | $ 12.2 K | ||
|
Aptorum Group Limited
APM
|
4.34 M | $ 0.81 | 1.31 % | $ 4.42 M | ||
|
Aeglea BioTherapeutics
AGLE
|
58.7 M | - | - | $ 1.01 B | ||
|
Atea Pharmaceuticals
AVIR
|
18.6 M | $ 4.66 | 1.42 % | $ 393 M | ||
|
AIkido Pharma
AIKI
|
3.78 M | - | 1.93 % | $ 17.4 M | ||
|
I-Mab
IMAB
|
576 M | - | - | $ 866 M | ||
|
Axsome Therapeutics
AXSM
|
379 M | $ 167.61 | -4.09 % | $ 8.34 B | ||
|
Akero Therapeutics
AKRO
|
39.8 M | - | - | $ 3.67 B | ||
|
Albireo Pharma
ALBO
|
45.3 M | - | -0.23 % | $ 916 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
1.62 B | - | - | $ 40.3 B | ||
|
Allena Pharmaceuticals
ALNA
|
15.7 M | - | 3.16 % | $ 1.9 M | ||
|
AlloVir
ALVR
|
5.24 M | - | 4.14 % | $ 49.1 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.77 M | - | -1.52 % | $ 24.7 M | ||
|
Ampio Pharmaceuticals
AMPE
|
2.38 M | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
15.1 M | - | - | $ 10.1 M | ||
|
Akouos
AKUS
|
16.8 M | - | 0.23 % | $ 488 M | ||
|
BioVie
BIVI
|
2.27 M | $ 1.25 | 0.4 % | $ 1.85 M | ||
|
Acorda Therapeutics
ACOR
|
228 M | - | -24.86 % | $ 820 K | ||
|
Acer Therapeutics
ACER
|
19 M | - | 2.71 % | $ 14 M | ||
|
Aravive
ARAV
|
22.1 M | - | -13.39 % | $ 1.45 M | ||
|
Институт стволовых клеток человека
ISKJ
|
556 M | - | - | - | ||
|
BioMarin Pharmaceutical
BMRN
|
607 M | $ 63.02 | 0.15 % | $ 12 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
25.2 M | - | - | $ 26.5 M | ||
|
Alpine Immune Sciences
ALPN
|
58 M | - | - | $ 2.17 B | ||
|
Catalyst Biosciences
CBIO
|
20 M | $ 12.71 | 10.81 % | $ 837 M | ||
|
Capricor Therapeutics
CAPR
|
31.3 M | $ 27.89 | 0.07 % | $ 747 M | ||
|
Aptose Biosciences
APTO
|
4.46 M | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
6.29 M | - | -39.0 % | $ 4.57 M | ||
|
Avenue Therapeutics
ATXI
|
816 K | - | -52.27 % | $ 4.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
36.9 M | - | 17.91 % | $ 11.1 M | ||
|
Amneal Pharmaceuticals
AMRX
|
1.13 B | $ 14.72 | 2.08 % | $ 4.55 B | ||
|
Arena Pharmaceuticals
ARNA
|
66.3 M | - | -6.81 % | $ 3.04 B | ||
|
Certara
CERT
|
146 M | $ 6.67 | 2.77 % | $ 1.07 B | ||
|
Athira Pharma
ATHA
|
13.1 M | - | - | $ 269 M | ||
|
Athersys
ATHX
|
29.9 M | - | 3.77 % | $ 22.4 M | ||
|
Autolus Therapeutics plc
AUTL
|
60.7 M | $ 1.85 | 6.65 % | $ 472 M |